Literature DB >> 7051404

Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients.

K M Taylor, W H Bain, K G Davidson, M A Turner.   

Abstract

Pulsatile perfusion has been shown to offer significant haemodynamic advantages over non-pulsatile perfusion in many experimental studies. Clinical acceptance of pulsatile perfusion during cardiac surgical procedures has, however, been hampered by the lack of technologically satisfactory pulsatile pump systems, and by inadequate clinical experience of routine use of pulsatile perfusion. The recent introduction of reliable pulsatile pump systems with low haemolysis characteristics has made possible the clinical validation of the previous experimental studies. We describe the results of a prospective study of mortality, haemodynamic morbidity, and haematological status, in 350 consecutive adult patients submitted to cardiopulmonary bypass procedures in a surgical unit over a 12-month period. One hundred and seventy five patients were perfused with conventional non-pulsatile flow and 175 with pulsatile flow, using a modified roller-pump pulsatile system (Cobe-Stockert). The groups were closely similar in terms of preoperative characteristics, referral category, and pathology requiring surgery. Operative techniques, bypass parameters, and anaesthetic regime were standardised in both groups. The results were as follows. (1) Total mortality was significantly lower in the pulsatile group (4.6%) compared with the non-pulsatile group (10.3%), p = 0.06. (2) The incidence of deaths attributable to post-perfusion low cardiac output was significantly lower in the pulsatile group (1.1% compared with 6.3%, p = 0.02). (3) Requirement for mechanical (intra-aortic balloon) or drug circulatory support was significantly lower in the pulsatile group. (4) The use of pulsatile perfusion was not associated with any increase in haemolysis, blood cell depletion, or postoperative bleeding problems.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051404      PMCID: PMC459311          DOI: 10.1136/thx.37.5.324

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  PULSATILE AND NONPULSATILE BLOOD FLOW.

Authors:  I MANDELBAUM; W H BURNS
Journal:  JAMA       Date:  1965-02-22       Impact factor: 56.272

2.  Systemic hypertension following myocardial revascularization.

Authors:  F G Estafanous; R C Tarazi; J F Viljoen; M Y el-Tawil
Journal:  Am Heart J       Date:  1973-06       Impact factor: 4.749

3.  Hemodynamic, metabolic, and hematologic effects of pulsatile cardiopulmonary bypass.

Authors:  J Dunn; M M Kirsh; J Harness; M Carroll; J Straker; H Sloan
Journal:  J Thorac Cardiovasc Surg       Date:  1974-07       Impact factor: 5.209

4.  A simple method of producing pulsatile flow during clinical cardiopulmonary bypass.

Authors:  G Pappas
Journal:  Ann Thorac Surg       Date:  1974-04       Impact factor: 4.330

5.  The Morton-Keele pump--a hydraulically activated pulsatile pump for use in extracorporeal circulation.

Authors:  J M Sanderson; P G Morton; T S Tolloczko; T Vennart; G Wright
Journal:  Med Biol Eng       Date:  1973-03

6.  Transient systolic hypertension after aortic valve replacement.

Authors:  M J McQueen; M E Watson; W H Bain
Journal:  Br Heart J       Date:  1972-03

7.  Pulmonary function during pulsatile and nonpulsatile right heart bypass.

Authors:  R R Wemple; L F Mockros; F J Lewis
Journal:  J Thorac Cardiovasc Surg       Date:  1969-02       Impact factor: 5.209

8.  Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man.

Authors:  H Gavras; D Kremer; J J Brown; B Gray; A F Lever; R F MacAdam; A medina; J J Morton; J I Robertson
Journal:  Am Heart J       Date:  1975-03       Impact factor: 4.749

9.  Hemodynamic effects of pulsatile and nonpulsatile flow.

Authors:  F Giron; W C Birtwell; H S Soroff; R A Deterling
Journal:  Arch Surg       Date:  1966-11

10.  Hemodynamic and ventilatory responses to fentanyl, fentanyl-droperidol, and nitrous oxide in patients with acquired valvular heart disease.

Authors:  R K Stoelting; P S Gibbs; C W Creasser; C Peterson
Journal:  Anesthesiology       Date:  1975-03       Impact factor: 7.892

View more
  7 in total

1.  Mechanical circulatory support with the ABIOMED BVS 5000: the Toronto General Hospital experience.

Authors:  Vidyadhar Lad; Abdelsalam Elhenawy; Steve Harwood; Jane Maciver; Mitesh Vallabh Badiwala; Mark Vallelonga; Terrence M Yau; Robert J Cusimano; Diego H Delgado; Heather J Ross; Vivek Rao
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

2.  Pulsatile versus non-pulsatile flow to reduce cognitive decline after coronary artery bypass surgery: A randomized prospective clinical trial.

Authors:  Koray Aykut; Gokhan Albayrak; Mehmet Guzeloglu; Eyup Hazan; Muge Tufekci; Ipek Erdoğan
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

Review 3.  Chronic nonpulsatile blood flow is compatible with normal end-organ function: implications for LVAD development.

Authors:  Satoshi Saito; Tomohiro Nishinaka
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

4.  A pulsatile pump for cardiopulmonary bypass and its clinical use.

Authors:  Y Sasaki; T Kawai; K Nishiyama; Y Murayama; S Toda; T Wada; K Kitaura; S Sato; M Kadowaki; Y Kanki
Journal:  Jpn J Surg       Date:  1988-09

5.  Pulsatile cardiopulmonary bypass for patients with renal insufficiency.

Authors:  G N Olinger; L D Hutchinson; L I Bonchek
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

6.  The effect of Ventricular Assist Devices on cerebral autoregulation: A preliminary study.

Authors:  Judith Bellapart; Gregory S Chan; Yu-Chieh Tzeng; Philip Ainslie; Adrian G Barnett; Kimble R Dunster; Rob Boots; John F Fraser
Journal:  BMC Anesthesiol       Date:  2011-02-22       Impact factor: 2.217

Review 7.  Arterial pressure and cerebral blood flow variability: friend or foe? A review.

Authors:  Caroline A Rickards; Yu-Chieh Tzeng
Journal:  Front Physiol       Date:  2014-04-07       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.